Family Care Center reveals shocking breakthrough in treating anxiety and depression
- Family Care Center has published new research demonstrating a novel treatment approach for anxiety in patients with major depressive disorder.
- The study showed significant symptom reductions in 82 patients participating in 30 sessions of the novel SBL rTMS protocol.
- The findings suggest a promising new treatment option for individuals facing both anxiety and depression.
On December 16, 2024, the Family Care Center based in the United States published significant findings regarding a new treatment for patients suffering from anxiety alongside major depressive disorder. The research specifically evaluated the effectiveness of a sequential bilateral (SBL) repetitive transcranial magnetic stimulation (rTMS) protocol, which was found to considerably alleviate anxiety symptoms in individuals diagnosed with major depressive disorder. A total of 82 patients, who experienced moderate to severe anxiety, underwent 30 SBL rTMS sessions throughout the study period. Assessment scores from the Generalized Anxiety Disorder-7 (GAD-7) indicated notable reductions in anxiety symptoms at both the midpoint and conclusion of the treatment, marking progress in this complex area of mental health. Furthermore, these results build on earlier findings from Family Care Center that highlighted the benefits of the same SBL rTMS protocol in reducing depressive symptoms among patients with treatment-resistant depression. The methodology, developed by Chief Medical Officer Dr. Chuck Weber, stands out for its innovative approach of applying high-frequency stimulation to the left side of the brain, followed by theta burst stimulation patterns on the right side. This unique method appears to provide an effective path forward for individuals struggling with the dual challenges of anxiety and depression. Dr. Sabrina Segal, a co-author of the research, emphasized the commitment of Family Care Center to advancing treatment options for complex mental health disorders. The combined methods of therapy, medication management, and TMS have led to a surprisingly high rate of positive outcomes, reported at 95%, far exceeding the national average of 52%. Though the findings are promising, the researchers note the necessity for further studies to validate and enhance the understanding of this treatment process. Overall, the findings from Family Care Center’s recent published study not only reinforce their ongoing dedication to innovate in behavioral health treatments, but they also spark optimism regarding the effective management of mental health conditions that traditionally present significant challenges for patients and healthcare providers alike.